ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -19 مورد

Vaccinations for adults (age >19 years) with impaired splenic function and adults undergoing splenectomy in the United States*

Vaccinations for adults (age >19 years) with impaired splenic function and adults undergoing splenectomy in the United States*
Vaccine Primary series Revaccination (booster)
Pneumococcal vaccine Refer to UpToDate content for details Refer to UpToDate content for details
Haemophilus influenzae type b vaccine
  • Hib
 1 doseΔ Not applicable
Meningococcal serotype ACWY vaccine
  • MenACWY (Menveo or MenQuadfi)◊
 2 doses at least 8 weeks apart§ Every 5 years
Meningococcal serotype B
  • MenB-FHbp (Trumenba) or MenB-4C (Bexsero)

3 doses at 0, 1 to 2, and 6 months¥

MenB formulations are not interchangeable. The same MenB formulation must be used for each dose of the primary series and all booster doses.

 1 year after completing the primary series and every 2 to 3 years thereafter
Seasonal influenza virus 1 dose annually at the start of influenza season Repeat annually at start of influenza season
COVID-19 Refer to UpToDate content for details Refer to UpToDate content for details
In addition to the vaccines above, patients with impaired splenic function should also receive all routinely recommended age-appropriate vaccines (including COVID-19 vaccination). For patients undergoing elective splenectomy, vaccinations should ideally be started approximately 10 to 12 weeks prior to surgery so that the recommended vaccine series can be completed at least 14 days prior to splenectomy. For patients undergoing emergency splenectomy, vaccine series should be started 14 days after splenectomy. For patients with nonsurgical asplenia or hyposplenism, vaccinations should be given as soon as impaired splenic function is recognized.

COVID-19: coronavirus disease 2019.

* Available vaccine formulations and recommendations may differ outside of the United States.

¶ Pneumococcal vaccine regimens have become more complex as more formulations have become available. Refer to UpToDate topics and tables on pneumococcal vaccination.

Δ Hib vaccination is recommended for all adults who have not been previously vaccinated or if vaccination status is unknown.

◊ Another MenACWY-TT vaccine (Nimenrix) is licensed in some countries outside the United States.

§ If primary series already received, continue revaccinating every 5 years.

¥ If not already received.

Graphic 119180 Version 10.0